top of page
MedMira
Sep 27, 20233 min read
Update on MedMira’s Regulatory Path in Canada and the USA
Halifax, Nova Scotia, 27 September, 2023 – Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on its progress to achieve...
MedMira
Mar 29, 20232 min read
Finger-Prick Test Developed For ‘Trich’ A Common, Undiagnosed STI
https://scienceblog.com/537081/finger-prick-test-developed-for-trich-a-common-undiagnosed-sti/ A quick, affordable diagnostic test...
MedMira
Mar 24, 20231 min read
MedMira receives 3 new trademarks
MedMira has been notified that the Company has successfully defended its claim on its submitted trademarks. VYRA U.S. Serial Number:...
MedMira
Mar 14, 20233 min read
Update on MedMira’s Reveal® TP (Syphilis) Clinical Trials in Canada
Halifax, Nova Scotia, 14 March, 2023 – Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on its progress to achieve regulatory...
MedMira
Feb 20, 20233 min read
MedMira enters into Partnership with Maternova for USA and Latin America
Halifax, Nova Scotia, 20 Februrary, 2023 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the singing of a multinational...
MedMira
Jan 31, 20231 min read
Public Information
The Company planned to issue a Press Release with a commercial update this month. Due to a highly positive change in the commercial...
bottom of page